In Mesothelioma, Wendy et al. reported that RRM2 was highly expressed in MESO by semi-quantitative immunohistochemical analysis in 70 patients, but no significant correlation was observed between RRM2 expression and the clinical prognosis of OS and PFS [32]. This evidence concerns the gene RRM2 and mesothelioma.